MENU
IHE
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

IHE Price Prediction, iShares US Pharmaceuticals ETF AI Recommendations

Category: @Health
IHE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (null:LLY), Johnson & Johnson (null:JNJ), Merck & Co (null:MRK), Pfizer (null:PFE), Bristol-Myers Squibb Co (null:BMY), ZOETIS (null:ZTS), Elanco Animal Health (null:ELAN), Intra-Cellular Therapies (null:ITCI).

Industry description

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares US Pharmaceuticals ETF ETF is 55.87B. The market cap for tickers in the group ranges from 221.06M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is AMLX at 221.06M.

High and low price notable news

The average weekly price growth across all stocks in the iShares US Pharmaceuticals ETF ETF was -1%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was 8%. AMLX experienced the highest price growth at 12%, while AXSM experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the iShares US Pharmaceuticals ETF ETF was 3%. For the same stocks of the ETF, the average monthly volume growth was -12% and the average quarterly volume growth was -20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 64
Price Growth Rating: 51
SMR Rating: 72
Profit Risk Rating: 66
Seasonality Score: 22 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com